Interferon Signaling Is Frequently Downregulated in Melanoma

Immune checkpoint inhibitors that block the programmed cell death protein 1/PD-L1 pathway have significantly improved the survival of patients with advanced melanoma. Immunotherapies are only effective in 15–40% of melanoma patients and resistance is associated with defects in antigen presentation a...

Descripción completa

Detalles Bibliográficos
Autores principales: Alavi, Sara, Stewart, Ashleigh Jacqueline, Kefford, Richard F., Lim, Su Yin, Shklovskaya, Elena, Rizos, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021492/
https://www.ncbi.nlm.nih.gov/pubmed/29977240
http://dx.doi.org/10.3389/fimmu.2018.01414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021492/
https://www.ncbi.nlm.nih.gov/pubmed/29977240
http://dx.doi.org/10.3389/fimmu.2018.01414

Ejemplares similares